The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo

Journal of Biological Chemistry

Volumn 287, Issue 17, 2012, Pages 13633-13643

  Linley, Adam J ^a   Mathieu, Morgan G ^a   Miles, Amanda K ^a   Rees, Robert C ^a   McArdle, Stephanie E B ^a   Regad, Tarik ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATP-BINDING CASSETTE; BROAD APPLICATION; CANCER THERAPY; CONCOMITANT DECREASE; HELICASE ACTIVITIES; HELICASES; IN-VITRO; IN-VIVO; MALIGNANT MELANOMA; MELANOMA CELLS; MELANOMA TUMORS; NEUROBLASTOMAS; NON-OBESE DIABETICS; PROTEIN EXPRESSIONS; SIGNALING PATHWAYS; TUMOR GROWTH; TUMORIGENESIS;

CELL CULTURE; CELL PROLIFERATION; CELLS; DERMATOLOGY; POPULATION STATISTICS; TUMORS;

ONCOLOGY;

ABC BINDING CASSETTE SUBFAMILY B MEMBER 5; ABC TRANSPORTER; DEAD BOX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84860004429     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.308973     Document Type: Article

References (42)

1. Martelange, V., De Smet, C., De Plaen, E., Lurquin, C., and Boon, T. (2000) Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res. 60, 3848-3855 (Pubitemid 32204577)
2. Caruthers, J. M., and McKay, D. B. (2002) Helicase structure and mechanism. Curr. Opin. Struct. Biol. 12, 123-133 (Pubitemid 34142730)
3. Silverman, E., Edwalds-Gilbert, G., and Lin, R. J. (2003) DExD/H-box proteins and their partners. Helping RNA helicases unwind. Gene 312, 1-16
4. Fuller-Pace, F. V. (2006) DExD/H box RNA helicases. Multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 34, 4206-4215
5. Cordin, O., Banroques, J., Tanner, N. K., and Linder, P. (2006) The DEAD-box protein family of RNA helicases. Gene 367, 17-37 (Pubitemid 43286737)
6. Linder, P. (2006) Dead-box proteins. A family affair-active and passive players in RNP-remodeling. Nucleic Acids Res. 34, 4168-4180
7. Jankowsky, A., Guenther, U. P., and Jankowsky, E. (2011) Nucleic Acids Res. 39, 338-341
8. Linder, P., and Jankowsky, E. (2011) From unwinding to clamping. The DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 12, 505-516
9. Amler, L. C., Schürmann, J., and Schwab, M. (1996) The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosomes Cancer 15, 134-137
10. Godbout, R., Packer, M., and Bie, W. (1998) Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J. Biol. Chem. 273, 21161-21168 (Pubitemid 28385405)
11. Eberle, J., Fecker, L. F., Bittner, J. U., Orfanos, C. E., and Geilen, C. C. (2002) Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1. Br. J. Cancer 86, 1957-1962
12. Akao, Y., Marukawa, O., Morikawa, H., Nakao, K., Kamei, M., Hachiya, T., and Tsujimoto, Y. (1995) The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55, 3444-3449
13. Por, E., Byun, H. J., Lee, E. J., Lim, J. H., Jung, S. Y., Park, I., Kim, Y. M., Jeoung, D. I., and Lee, H. (2010) The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner. J. Biol. Chem. 285, 14475-14485
14. Frank, N. Y., Margaryan, A., Huang, Y., Schatton, T., Waaga-Gasser, A. M., Gasser, M., Sayegh, M. H., Sadee, W., and Frank, M.H. (2005) ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65, 4320-4333 (Pubitemid 40775671)
15. Frank, N. Y., Schatton, T., Kim, S., Zhan, Q., Wilson, B. J., Ma, J., Saab, K. R., Osherov, V., Widlund, H. R., Gasser, M., Waaga-Gasser, A. M., Kupper, T. S., Murphy, G. F., and Frank, M. H. (2011) VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res. 71, 1474-1485
16. Wilson, B. J., Schatton, T., Zhan, Q., Gasser, M., Ma, J., Saab, K. R., Schanche, R., Waaga-Gasser, A. M., Gold, J. S., Huang, Q., Murphy, G. F., Frank, M. H., and Frank, N. Y. (2011) ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res. 71, 5307-5316
17. Na, Y. R., Seok, S. H., Kim, D. J., Han, J. H., Kim, T. H., Jung, H., and Park, J. H. (2009) Zebrafish embryo extracts promote sphere-forming abilities of human melanoma cell line. Cancer Sci. 100, 1429-1433
18. Camats, M., Guil, S., Kokolo, M., and Bach-Elias, M. (2008) p68 RNA helicase (DDX5) alters activity of cis- and trans-acting factors of the alternative splicing of H-Ras. PLoS ONE 3, 2926
19. Janknecht, R. (2010) Multi-talented DEAD-box proteins and potential tumor promoters. p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am. J. Transl. Res. 2, 223-234
20. Manoukian, A. S., and Woodgett, J. R. (2002) Role of glycogen synthase kinase-3 in cancer. Regulation by Wnts and other signaling pathways. Adv. Cancer Res. 84, 203-229 (Pubitemid 34188198)
21. Ding, Q., Xia, W., Liu, J. C., Yang, J. Y., Lee, D. F., Xia J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., Bargou, R. C., Qin, J., Lai, C. C., Tsai, F. J., Tsai, C. H., and Hung, M. C. (2005) Erk associates with and primes GSK-3β for its inactivation resulting in up-regulation of β-catenin. Mol. Cell. 19, 159-170 (Pubitemid 41019664)
22. Asada, S., Daitoku, H., Matsuzaki, H., Saito, T., Sudo, T., Mukai, H., Iwashita, S., Kako, K., Kishi, T., Kasuya, Y., and Fukamizu, A. (2007) Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell. Signal. 19, 519-527 (Pubitemid 46107803)
23. Huang, H., and Tindall, D. J. (2007) Dynamic FoxO transcription factors. J. Cell Sci. 120, 2479-2487 (Pubitemid 47323857)
24. Downward, J. (2003) Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22
25. Giehl, K. (2005) Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 386, 193-205
26. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell. 103, 211-225
27. Causevic, M., Hislop, R. G., Kernohan, N. M., Carey, F. A., Kay, R. A., Steele, R. J., and Fuller-Pace, F. V. (2001) Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20, 7734-7743 (Pubitemid 33121946)
28. Shim, H., Shim, E., Lee, H., Hahn, J., Kang, D. et al. (2006) CAGE, a novel cancer/testis antigen gene, promotes cell motility by activation ERK and p38 MAPK and down-regulating ROS. Mol. Cell. 21, 367-375 (Pubitemid 44027685)
29. Clark, E. L., Coulson, A., Dalgliesh, C., Rajan, P., Nicol, S. M., Fleming, S., Heer, R., Gaughan, L., Leung, H. Y., Elliott, D. J., Fuller-Pace, F. V., and Robson, C. N. (2008) The RNA helicase p68 is a novel androgen receptor co-activator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 6, 7938-7946
30. Kim, Y., Park, H., Park, D., Lee, Y. S., Choe, J., Hahn J. H., Lee, H., Kim, Y. M., and Jeoung, D. (2010) Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. J. Biol. Chem. 285, 25957-25968
31. Fuller-Pace, F. V., and Moore, H. C. (2011) RNA helicases p68 and p72. Multifunctional proteins with important implications for cancer development. Future Oncol. 7, 239-251
32. Kim, Y., and Jeoung, D. (2008) Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility. J. Microbiol. Biotechnol. 18, 600-610
33. Liggins, A. P., Lim, S. H., Soilleux, E. J., Pulford, K., and Banham, A. H. (2010) A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. Cancer Immun. 10, 8
34. Mathieu, M. G., Linley, A. J., Reeder, S. P., Badoual, C., Tartour, E., Rees, R. C., and McArdle, S. E. (2010) HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer Immun. 10, 2
35. Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., Fuhlbrigge, R. C., Kupper, T. S., Sayegh, M. H., and Frank, M. H. (2008) Identification of cells initiating human melanomas. Nature 451, 345-349
36. Shields, J. M., Pruitt, K., McFall, A., Shaub, A., and Der, C. J. (2000) Understanding Ras. "It ain't over 'til it's over." Trends Cell Biol. 10, 147-154 (Pubitemid 30171309)
37. Mitin, N., Rossman, K. L., and Der, C. J. (2005) Signaling interplay in Ras superfamily function. Curr. Biol. 15, 563-574
38. Wennerberg, K., Rossman, K. L., and Der, C. J. (2005) The Ras superfamily at a glance. J. Cell Sci. 118, 843-846 (Pubitemid 40484876)
39. Bos, J. L. (1989) Ras oncogenes in human cancer.Areview. Cancer Res. 49, 4682-4689
40. Campbell, P. M., and Der, C. J. (2004) Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin. Cancer Biol. 14, 105-114 (Pubitemid 38234752)
41. Castellano, E., and Downward, J. (2010) Role of RAS in the regulation of PI 3-kinase. Curr. Top. Microbiol. Immunol. 346, 143-169
42. Christensen, C., and Guldberg, P. (2005) Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF. Oncogene 24, 6292-6302 (Pubitemid 43080052)